Commercial Litigation Finance: How Big is This Thing?

The following article is part of an ongoing column titled ‘Investor Insights.’ 

Brought to you by Ed Truant, founder and content manager of Slingshot Capital, ‘Investor Insights’ will provide thoughtful and engaging perspectives on all aspects of investing in litigation finance. 

Executive Summary

MarketAustralia (AUS$)UK (£)USA (US$)
Implied Commitment CapacityAUS $1B£2BUS $10B
Implied Annual commitments1AUS $333MM£667MMUS $3.3B

The chart above summarizes the results of quantifying the size of the most mature markets for litigation finance.  If you were to attempt to perform the same analysis three years ago, I suspect you would find that the industry was less than half its current size.  Accordingly, it is a dynamic and growing market that should be on most investors’ radar screens if you are interested in non-correlated exposures.

Investor Insights

  • Growing, dynamic market
  • Diversification is critical to responsible investing; “tail risk” can be significant
  • Relatively few managers with long track records
  • New investors should focus on the small subset of experienced fund managers

Approach and Limitation of Sizing

I am often asked about the size of the commercial litigation finance market by individual and institutional investors alike, whether relative to the US market or other large global markets. I often hesitate to answer the question as the answer is dependent on an element of transparency not currently inherent in the industry itself.  Nevertheless, I think it is important for all stakeholders to understand the size of an industry, so investors can determine whether it has the scale and growth attributes necessary to justify a long-term approach to investing in the sector.

However, before I describe the approaches taken, I think it is important to recognize the limitations of attempting to size the industry, as past estimates have varied wildly.

Limitation #1: Dedicated Funds vs. Opaque Capital Pools vs. Non-Organized Capital Pools

While there are many dedicated litigation funders (“Funders”) servicing the global marketplace, both private and publicly-traded, they only represent a portion of the available financing for the industry (especially in the US). Even the Funders that service the market are relatively private about the amount of capital they have available and the amount of capital they deploy annually (not to mention committed capital vs. drawn capital).  On the odd occasion, you will have a funder trumpet their latest close size, but it is often just a headline number and you are left wondering exactly what it means as it could be inclusive of co-invest capacity, side cars, discretionary separately managed accounts, etc.

Then there are the Opaque Capital Pools.  These are the hedge funds, the multi-strategy funds with a sliver of their fund dedicated to litigation finance, merchant banks, credit funds, etc.  Even PIMCO, the world’s largest bond fund, has allocated capital to one of the UK funders (a tiny allocation for PIMCO, but perhaps the ‘thin edge of the wedge,’ if they achieve success).  The problem from a data perspective is that many of these funding sources don’t disclose how much of their capital has been allocated to litigation finance, as they don’t necessarily want the world, or their competitors, to know where they are investing.

Finally, there are a host of other financiers in the marketplace, which I will refer to as Disorganized Capital Pools.  These are the lawyers, law firms, High Net Worth (HNW) and Ultra HNW (UHNW) individual investors, family offices and the like that have decided they want exposure to single case risks or portfolios thereof.  Investors who have not dedicated a lot of time and attention to the asset class are probably best served by investing in a series of funds, as opposed to going direct with one manager or a series of individual cases.

Often times, the second and third categories are what I call flexible pools of capital, meaning that if they achieve success in investing they will allocate more capital, and if they don’t have a positive experience they will retreat and ‘run-off’ their remaining investments, and “chalk that one up to experience”.   The Opaque Capital Pools and Disorganized Capital Pools are what I refer to as “Non-Fund Investors”.  Accordingly, due to the flexibility and private nature of the Opaque and Disorganized Capital Pools, it is difficult to determine the exact amount of capital they represent at any given point in time.

Limitation #2: Financing Fees vs. Financing Out of Pocket

There is a distinction in the industry between financing legal fees (which is not always possible in all jurisdictions) and financing out-of-pocket expenses (court costs, discovery costs, expert reports, etc.).  There is also a third bucket where financiers will provide “working capital” as part of their litigation finance commitment. Funds which provide working capital are grounded in a belief by the Funder that the piece of litigation has value, and if the value exceeds the various costs necessary to pursue the case, then they are comfortable providing any excess capital to the business for working capital purposes.  The other aspect to working capital is that the litigation funder does not want to find itself in the middle of litigation with an insolvent enterprise where the management team is no longer focused on the litigation prize, and so they argue it is in their best interest to keep the company solvent while the litigation is being pursued.  Arguably, working capital loans belong in the world of specialty finance, not litigation finance, but in this case the underlying security is the outcome of the litigation.

The reason I draw the first distinction is because it could be argued that a large segment of litigation finance is already being provided through contingent fee arrangements, which have been in existence for decades in the US, but have been the sole purview of lawyers.  Should these contingent fees count towards industry sizing?  I think a logical argument can be made that they should be included, as these are funds that could or would otherwise be provided by a third-party litigation funder, but then again, they will never be funded by Funders. Some people believe that law firms are taking the best cases for themselves and the litigation funding industry is fighting for the cast-offs (termed ‘adverse selection risk’).  I don’t necessarily subscribe to this theory, as the high success rates in the Litigation Finance industry support the notion that good cases are being undertaken by third party funders.

Interestingly, one of the world’s largest law firms, Kirkland & Ellis, recently announced that they are going to double down on their contingent fee arrangements through the establishment of a plaintiff side litigation group, which was previously the sole purview of scrappy plaintiff side lawyers (many of whom have achieved tremendous financial success in doing so). Perhaps the grass really is greener…

For the purpose of this article, I have assumed that contingent fees are not included in the industry sizing exercise.

Limitation #3: It’s Getting Global

A few years ago, the various funders were entrenched in their local jurisdictions and happy to toil away in their own back yards. Then something interesting happened.  It got global, fast!  Over the last 3-5 years, the industry saw litigation funders move outside of their home base, and do so in a significant way.  UK funders moved into the US, Australian funders moved into the US and UK, UK funders moved into Australia, and more recently, some funders figured my host country, Canada, was also an interesting opportunity.  Is this a reflection of their local markets being saturated, or is this a global ‘land grab’? I point this out because when you analyze pools of capital by litigation funders, you cannot solely look at where that funder is domiciled and conclude their capital is solely dedicated to their home country.  Some funders, like IMF Bentham, have set up dedicated pools to service the US and other pools to service Rest of World (i.e. ex-US).  Other funders do not have dedicated pools, but look for the best risk-adjusted opportunities around the globe, or in specific markets in which they are comfortable investing (typically other English common law or common law derived markets, but not necessarily so).  I say this because the available data forces one to look at global litigation funding sizing, as it is difficult to know where the funder will deploy its capital.  This doesn’t even consider foreign exchange rate fluctuations and their effect on industry sizing – the Brexit impact on the GBP would have had a significant impact on the USD equivalent alone.

Limitation #4: Cultural Differences and Punitive Damages

There is no arguing that the US is a much more permissive culture in terms of utilizing litigation to settle differences – ‘nothin’ like a good gun fight to settle a dispute’, one might say.  This means that while the size of the litigation industry is much larger, one could argue that you have to parse out the less meritorious claims to find the jewels that litigation finance would support – their money is not frivolous, hence the cases they fund are also not frivolous. Accordingly, when you look at the size of the entire industry, you must assign a lower litigation funding applicability rate in the US because of the aggressive nature of the claim environment (i.e. while the US legal market is much larger because the culture is more permissive, there are a smaller percentage of claims that attract litigation finance).

The second and more important issue, is the relative extent of punitive damages in the American civil justice system vs other civil justice systems.  There is no doubt – and it has been well documented through empirical evidence – that awards are larger in the US.  Accordingly, this would suggest that comparing data from other jurisdictions and applying that to try and size the US market, or any other market for that matter, is somewhat limiting.

In addition, each market has its own nuances and peculiarities, and so it is very difficult to compare different jurisdictions and draw solid conclusions.  All of the aforementioned would suggest the industry is difficult to size with any degree of accuracy.  I think there is some truth to that supposition.

Limitation #5 – What is included in “Commercial”?

While the commercial litigation finance market is generally defined to include financing of litigation involving two corporate entities, the funders involved in the space have expanded the definition to include, amongst other things, Investor-State, product class action and insolvency cases where there is typically not another commercial entity on the other side of the dispute, but rather a sovereign, a set of consumers or an individual (director or shareholder), respectively.  Accordingly, the commercial litigation finance funders have expanded the definition of what is included in the market by including large, complex cases involving non-commercial entities.  Nevertheless, these cases are typically financed by commercial litigation finance funders and should be captured in the size estimates.

So, with all of the limitations above, I have tried to approach industry sizing using a pair of different approaches: micro and macro.

Macro Perspective: 

When looking at it from a macro perspective, I like to focus on one of the more mature markets for litigation finance and draw inferences – that market being Australia.

Australia is a common law market; it has been utilizing litigation finance for close to two decades, and therefore is one of the more mature markets, which suggests market penetration for Litigation Finance is relatively high.  The one limitation of using Australia as a benchmark is that the jurisdiction generally does not allow contingent fees, so arguably, litigation finance levels are higher because lawyers are not able to put their fees at risk, hence their fees are financed by Funders.  I also believe Australia has fewer Non-Funder investors than the United States, and so we can likely draw better conclusions about the size of their market by looking at the active funders there.

The following chart attempts to put the relative markets into perspective.

CountryContingent FeesAdverse CostsLitigation CultureLegal MarketFunding Type
USYesNoPermissive$437B USLegal fees, working capital & disbursements
UKYesYesModerate£29B GBPLegal fees & disbursements
AustraliaNoYesModerate$21B AUDLegal Fees, disbursements & indemnities

So, if one considers the Dedicated Funds in Australia, and tries to estimate the amount of capital they have dedicated to the local industry and compare that to the overall size of the litigation market (a number that is fairly well tracked), we can see that the Australian market is approximately AUS$200-300MM in annual commitments, and has commitment capacity of about 2-3 times that, or $500-750MM (using the mid-point).  This would suggest that litigation finance – in terms of annual commitments – represents about 1 to 1.5% of their $21B legal market (where the “legal market” is the market for all legal services, not just those dedicated to litigation).

Applying the same methodology to the UK market, and adjusting for the fact that contingent fees are more prevalent in the UK, one could argue that the UK market, being younger than the Australian market, should be less penetrated, with less capital being required due to contingent fees.  Perhaps the litigation finance market is closer to 1% of the legal market, or approximately £290MM and commitment capacity of 2-3 times that amount of £600-900MM.

Extending this logic to the US market, and allowing for a strong punitive damage system, strong contingent fee usage and a low relative penetration rate, we can surmise that the market is similarly close to 1% of the size of its legal market, or $4B in annual commitments with commitment capacity of 2-3 times that or $8-12B.

MarketAustralia (AUS$)UK (£)USA (US$)
Commitment CapacityAUS $500-750MM£600-900MMUS $8-12B
Annual CommitmentsAUS $ 2-300MM£250-350MMUS $3-4B

Micro Perspective:

The other approach to sizing the market is to build up the annual commitments and the commitment capacity on an investor-by-investor basis.  Westfleet Advisors has recently published a “Buyer’s Guide” to estimate the size of the US market using this approach, and their results seem to correlate with the approach I have used below.  The difference in results between our two approaches results from the size of the non-fund sources of capital, and my approach is admittedly a best guess estimate.  Nevertheless, I have used the following assumptions to try and triangulate the market sizes.  I took my knowledge of the various funders’ commitment capacity in each of the jurisdictions to determine the total commitment capacity of the market, and then I interpolated the size of the total market by estimating what percent of funding is represented by these Dedicated Funds.

MarketAustralia (AUS$)UK (£)USA (US$)
Fund Commitment CapacityAUS $1B£1.6BUS $5B
% of Market represented by Funders100%80%50%
Implied Commitment CapacityAUS $1B£2BUS $ 10B
Implied Annual commitments1AUS $333MM£667MMUS $3.3B
1 Annual commitments determined by dividing the Commitment Capacity by 3 (typical fund investment period, assuming extensions)

Conclusion

The two approaches seem to triangulate fairly well, and are buttressed by the micro analysis performed by WestFleet in the US market.  Accordingly, I think the two approaches provide a high-level view of the amount of capital available and annual commitments for the various jurisdictions.  While I would not rely on the exact figures, I believe the numbers are directionally correct, and provide investors with an order of magnitude assessment of the current market as to whether this market provides sufficient scale to justify a long-term exposure to the asset class, or whether investors should consider it a more opportunistic investment within one of their niche strategies or pools of capital.

While the industry is presently not sizable enough to attract many large pension plans and sovereign wealth funds that typically invest no less than $100’s of million at a time, it is quickly achieving a level of scale that has become attractive to some larger investors. By example, a large sovereign wealth fund has made a US$667MM commitment to Burford’s 2019 Private Partnership through a separately managed account.  The remaining external capital, $300 million, was provided by a series of small and medium-sized investors rumoured to include family offices, foundations, endowments and the like.  Whereas this scale of investor would not have invested in the asset class even three years ago, it appears the more aggressive of these investors have decided this is an asset class that merits serious consideration and investment, and I expect more to follow.

Investor Insight: For investors interested in investing in one of the truly non-correlated asset classes, they would be best to spend the time to analyze the various managers in the sector, of which there are relatively few on a global basis that I would consider “institutional” in nature.  They would also be well served to focus on those few managers with  a track record that includes fully realized funds, of which there are even fewer, or be prepared to spend the time and resources to assess the unrealized portion of those managers’ portfolios as ‘tail risk’ in this industry can be significant depending on the concentration of the portfolio.  As always, diversification is a key success factor to investing in this asset class as the idiosyncratic risk of cases and the binary nature of trial/arbitral awards make it particularly well suited for the application of portfolio theory.

Edward Truant is the founder of Slingshot Capital Inc. and an investor in the consumer and commercial litigation finance industry.

Commercial

View All

Computer Weekly Provides In-Depth History of Post Office Horizon Inquiry

By Harry Moran |

The Post Office Horizon IT scandal represented not only one of the most significant cases of institutional malpractice and miscarriage of justice in British history, but also catapulted the use of litigation funding into the public spotlight.

An article in Computer Weekly provides an in-depth summary of the statutory public inquiry into the Post Office Horizon IT scandal, giving readers a detailed account of all the key revelations that emerged across the last three years of the inquiry’s work. The feature breaks down these revelations on a chronological basis, starting in May 2022 with ‘phase one’ of the inquiry’s hearings and going all the way through to ‘phase seven’ in September 2024.

The feature explains how each of these seven phases gathered evidence on different aspects of the scandal, beginning in 2022 with phase one hearing testimonies from the victims, and the phase two investigation into the Horizon IT system itself.

Phase three saw the examination of the Horizon system over the subsequent year, whilst phase four switched focus to assess the activities of lawyers and investigators who participated in the subpostmasters’ prosecutions. Finally, the feature guides us through the inquiry’s work this year, with phases five and six putting the behaviour of directors, politicians and civil servants in the spotlight, before concluding with phase seven that took a broader look at the Post Office’s present and future.

Within the feature, readers can find links to individual articles that provide deep dives into each of these individual phases, cataloguing the most important pieces of evidence unearthed by the inquiry’s hearings. 

Community Spotlights

Community Spotlight: Dr. Detlef A. Huber, Managing Director, AURIGON LRC

By John Freund |

Detlef is a German attorney, former executive of a Swiss reinsurance company and as head of former Carpentum Capital Ltd. one of the pioneers of litigation funding in Latin America. Through his activities as executive in the insurance claims area and litigation funder he gained a wealth of experience in arbitrations/litigations in various businesses. He is certified arbitrator of ARIAS US and ARIAS UK (AIDA Reinsurance and Insurance Arbitration Society) and listed on the arbitrators panel of DIS (German Arbitration Institute).

He studied law in Germany and Spain, obtained a Master in European Law (Autónoma Madrid) and doctorate in insurance law (University of Hamburg).

Detlef speaks German, Spanish, English fluently and some Portuguese.

Company Name and Description:  AURIGON LRC (Litigation Risk Consulting) is at home in two worlds: dispute funding and insurance. They set up the first European litigation fund dedicated to Latin America many years ago and operate as consultants in the re/insurance sector since over a decade.

Both worlds are increasingly overlapping with insurers offering ever more litigation risk transfer products and funders recurring to insurance in order to hedge their risks. Complexity is increasing for what is already a complex product.

Aurigon acts as intermediary in the dispute finance sector and offers consultancy on relevant insurance matters.

Company Website: www.aurigon-lrc.ch

Year Founded: 2011, since 2024 offering litigation risk consulting  

Headquarters: Alte Steinhauserstr. 1, 6330 Cham/Zug Switzerland

Area of Focus:  Litigation funding related to Latin America and re/insurance disputes

Member Quote: “It´s the economy, stupid. Not my words but fits our business well. Dont focus on merits, focus on maths.”

Read More

Manolete Partners Releases Half-Year Results for the Six Months Ended 30 September 2024

By Harry Moran |

Manolete (AIM:MANO), the leading UK-listed insolvency litigation financing company, today announces its unaudited results for the six months ended 30 September 2024. 

Steven Cooklin, Chief Executive Officer, commented: 

“These are a strong set of results, particularly in terms of organic cash generation. In this six-month period, gross cash collected rose 63% to a new record at £14.3m. That strong organic cash generation comfortably covered all cash operating costs, as well as all cash costs of financing the ongoing portfolio of 413 live cases, enabling Manolete to reduce net debt by £1.25m to £11.9m as at 30 September 2024. 

As a consequence of Manolete completing a record number of 137 case completions, realised revenues rose by 60% to a further record high of £15m. That is a strong indicator of further, and similarly high levels, of near-term future cash generation. A record pipeline of 437 new case investment opportunities were received in this latest six month trading period, underpinning the further strong growth prospects for the business. 

The record £14.3.m gross cash was collected from 253 separate completed cases, highlighting the highly granular and diversified profile of Manolete’s income stream. 

Manolete has generated a Compound Average Growth Rate of 39% in gross cash receipts over the last five H1 trading periods: from H1 FY20 up to and including the current H1 FY25. The resilience of the Manolete business model, even after the extraordinary pressures presented by the extended Covid period, is now clear to see. 

This generated net cash income of £7.6m in H1 FY25 (after payment of all legal costs and all payments made to the numerous insolvent estates on those completed cases), an increase of 66% over the comparative six-month period for the prior year. Net cash income not only exceeded by £4.5m all the cash overheads required to run the Company, it also exceeded all the costs of running Manolete’s ongoing 413 cases, including the 126 new case investments made in H1 FY25. 

The Company recorded its highest ever realised revenues for H1 FY25 of £15.0m, exceeding H1 FY24 by 60%. On average, Manolete receives all the cash owed to it by the defendants of completed cases within approximately 12 months of the cases being legally completed. This impressive 60% rise in realised revenues therefore provides good near-term visibility for a continuation of Manolete’s strong, and well-established, track record of organic, operational cash generation. 

New case investment opportunities arise daily from our wide-ranging, proprietary, UK referral network of insolvency practitioner firms and specialist insolvency and restructuring solicitor practices. We are delighted to report that the referrals for H1 FY25 reached a new H1 company record of 437. A 27% higher volume than in H1 FY24, which was itself a new record for the Company this time last year. That points to a very healthy pipeline as we move forward into the second half of the trading year.” 

Financial highlights: 

  • Total revenues increased by 28% to £14.4m from H1 FY24 (£11.2m) as a result of the outstanding delivery of realised revenues generated in the six months to 30th September 2024.
    • Realised revenues achieved a record level of £15.0m in H1 FY25, a notable increase of 60% on H1 FY24 (£9.4m). This provides good visibility of near-term further strong cash generation, as on average Manolete collects all cash on settled cases within approximately 12 months of the legal settlement of those cases
    • Unrealised revenue in H1 FY25 was £(633k) compared to £1.8m for the comparative H1 FY24. This was due to: (1) the record number of 137 case completions in H1 FY25, which resulted in a beneficial movement from Unrealised revenues to Realised revenues; and (2) the current lower average fair value of new case investments made relative to the higher fair value of the completed cases. The latter point also explains the main reason for the marginally lower gross profit reported of £4.4m in this period, H1 FY25, compared to £5.0m in H1 FY24. 
  • EBIT for H1 FY25 was £0.7m compared to H1 FY24 of £1.6m. As well as the reduced Gross profit contribution explained above, staff costs increased by £165k to £2.3m and based on the standard formula used by the Company to calculate Expected Credit Losses, (“ECL”), generated a charge of £140k (H1 3 FY24: £nil) due to trade debtors rising to £26.8m as at 30 September 2024, compared to £21.7m as at 30 September 2023. The trade debtor increase was driven by the outstanding record level of £15.0m Realised revenues achieved in H1 FY25.
  • Loss Before Tax was (£0.2m) compared to a Profit Before Tax of £0.9m in H1 FY24, due to the above factors together with a lower corporation tax charge being largely offset by higher interest costs. 
  • Basic earnings per share (0.5) pence (H1 FY24: 1.4 pence).
  • Gross cash generated from completed cases increased 63% to £14.3m in the 6 months to 30 September 2024 (H1 FY24: £8.7m). 5-year H1 CAGR: 39%.
  • Cash income from completed cases after payments of all legal costs and payments to Insolvent Estates rose by 66% to £7.6m (H1 FY24: £4.6m). 5-year H1 CAGR: 46%.
  • Net cashflow after all operating costs but before new case investments rose by 193% to £4.5m (H1 FY24: £1.5m). 5-year H1 CAGR: 126%.
  • Net assets as at 30 September 2024 were £40.5m (H1 FY24: £39.8m). Net debt was reduced to £11.9m and comprises borrowings of £12.5m, offset by cash balances of £0.6m. (Net debt as 31 March 2024 was £12.3m.)
  • £5m of the £17.5m HSBC Revolving Credit Facility remains available for use, as at 30 September 2024. That figure does not take into account the Company’s available cash balances referred to above.

Operational highlights:

  • Ongoing delivery of record realised returns: 137 case completions in H1 FY25 representing a 18% increase (116 case realisations in H1 FY24), generating gross settlement proceeds receivable of £13.9m for H1 FY25, which is 51% higher than the H1 FY24 figure of £9.2m. This very strong increase in case settlements provides visibility for further high levels of cash income, as it takes the Company, on average, around 12 months to collect in all cash from previously completed cases.
  • The average realised revenue per completed case (“ARRCC”) for H1 FY25 was £109k, compared to the ARRCC of £81k for H1 FY24. That 35% increase in ARRCC is an important and an encouraging Key Performance Indicator for the Company. Before the onset and impact of the Covid pandemic in 2020, the Company was achieving an ARRCC of approximately £200k. Progress back to that ARRCC level, together with the Company maintaining its recent high case acquisition and case completion volumes, would lead to a material transformation of Company profitability.
  • The 137 cases completed in H1 FY25 had an average case duration of 15.7 months. This was higher than the average case duration of 11.5 months for the 118 cases completed in H1 FY24, because in H1 FY25 Manolete was able to complete a relatively higher number of older cases, as evidenced by the Vintages Table below.
  • Average case duration across Manolete’s full lifetime portfolio of 1,064 completed cases, as at 30 September 2024 was 13.3 months (H1 FY24: 12.7 months).
  • Excluding the Barclays Bounce Back Loan (“BBL”) pilot cases, new case investments remained at historically elevated levels of 126 for H1 FY25 (H1 FY24: 146 new case investments).
  • New case enquiries (again excluding just two Barclays BBL pilot cases from the H1 FY24 figure) achieved another new Company record of 437 in H1 FY25, 27% higher than the H1 FY24 figure of 343. This excellent KPI is a strong indicator of future business performance and activity levels.
  • Stable portfolio of live cases: 413 in progress as at 30 September 2024 (417 as at 30 September 2023) which includes 35 live BBLs.
  • Excluding the Truck Cartel cases, all vintages up to and including the 2019 vintage have now been fully, and legally completed. Only one case remains ongoing in the 2020 vintage. 72% of the Company’s live cases have been signed in the last 18 months.
  • The Truck Cartel cases continue to progress well. As previously reported, settlement discussions, to varying degrees of progress, continue with a number of Defendant manufacturers. Further updates will be provided as concrete outcomes emerge.
  • The Company awaits the appointment of the new Labour Government’s Covid Corruption Commissioner and hopes that appointment will set the clear direction of any further potential material involvement for Manolete in the Government’s BBL recovery programme.
  • The Board proposes no interim dividend for H1 FY25 (H1 FY24: £nil).

The full report of Manolete’s half-year results can be read here.

Read More